AcelaBio is a state-of-the-art contract research organization delivering end-to-end digital pathology and precision medicine laboratory services for pharmaceutical, biotech, and academic institutions. To facilitate biomarker discovery, we have implemented 10x Genomics Visium CytAssist spatial gene and protein expression alongside our CAP/CLIA certified anatomic pathology workflows. Once biomarkers are identified, AcelaBio can develop and validate highly sensitive and specific biomarker assays that can be implemented in a high-throughput setting to support clinical research and global clinical trials. AcelaBio employs operational, scientific, and medical experts, including U.S. Board Certified pathologists, who are dedicated to delivering reliable, high-quality data and imagery to accelerate biomarker discovery and development. As leading tissue experts, we facilitate a seamless process from wet lab to dry lab that translates your samples into meaningful insights.